DOSAGE REGIME
The present disclosure relates to the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to particular dosage regimens for the administration of ADCs which bind to CD19 (CD19-ADCs). La présente invention concerne...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present disclosure relates to the treatment of pathological conditions, such as cancer, with Antibody Drug Conjugates (ADCs). In particular, the present disclosure relates to particular dosage regimens for the administration of ADCs which bind to CD19 (CD19-ADCs).
La présente invention concerne le traitement d'états pathologiques, tels que le cancer, avec des conjugués anticorps-médicaments (CAM). En particulier, la présente invention concerne de nouveaux régimes posologiques pour l'administration de CAM qui se lient à CD19 (CAM-CD19). |
|---|